According to the recent report by IMARC Group, titled “Artificial Intelligence in Healthcare Market Report by Offering (Hardware, Software, Services), Technology (Machine Learning, Context Aware Computing, Natural Language Processing, and Others), Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), End-User (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Patients, and Others), and Region 2025-2033,” the global artificial intelligence in healthcare market reached a value of USD 7.8 Billion in 2024. Artificial intelligence (AI) in healthcare uses several software programs with complex algorithms that can replicate human senses in the analysis, interpretation, and comprehension of medical data. AI aids in evaluating the symptoms and patterns of diseases to offer better support, guidance, and feedback to healthcare providers. Apart from performing clinical diagnosis, it also helps in drug development, providing proper treatment plans for the ailment detected, offering personalized medicine, and monitoring patients’ condition. The incorporation of AI in the healthcare industry has made drug discovery and development more cost-effective, time-efficient, and innovative. With the latest developments, individuals can now track their health status on smart wearable devices.
Global Artificial Intelligence in Healthcare Market Trends:
The outbreak of the coronavirus disease (COVID-19) has decreased the frequency of physical consultations due to lockdowns and social distancing measures. As a result, AI technologies are widely being used in the healthcare sector for offering virtual consultations, diagnosis, and treatment to patients. In addition to this, multiple biotechnology and pharmaceutical companies are adopting the latest technologies to expedite vaccine development for COVID-19, thereby spurring the growth of the market. Additionally, several companies raised investments in healthcare AI startups in 2019, which is acting as another major growth-inducing factor for the market. For example, a United Kingdom-based AI healthcare provider, Babylon Health, raised $550 million. Furthermore, possibilities of decreasing medical costs, along with the rising gap between healthcare professionals and the pool of patients, are expected to create a positive outlook for the market. For instance, AI imaging tools can screen chest X-rays for any signs of tuberculosis, which mitigates human work, thereby bridging the resource gap. Looking forward, the market value is projected to reach USD 68.7 Billion by 2033, expanding at a CAGR of 26.04% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Offering, Technology, Application, End-User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Amazon Web Services Inc., Cloudmedx Inc., DeepMind, Enlitic Inc., General Vision Inc., Google Inc., International Business Machines, iCarbonX, Intel Corporation, Medtronic, Micron Technology Inc., Microsoft Corporation, Next It Corporation, Nuance Communications Inc., Nvidia Corporation, Siemens Healthcare and Welltok Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800